Month Analysis News Today

– Data from clinical studies of STK-001 demonstrated clinical benefit for patients ages 2 to 18 years old, including reductions in seizures and improvements in cognition and behavior that support...

– Data from clinical studies of STK-001 demonstrated clinical benefit for patients ages 2 to 18 years old, including reductions in seizures and improvements in cognition and behavior that support the potential for disease modification –– Analysis of 72 patients treated in STK-001 clinical trials suggests that higher...

– New data include 24-month results from the largest and longest prospective natural history study of children and adolescents with Dravet syndrome, which showed a lack of improvement despite...

Planning to embark on a trip to Colorado? These are the months which are considered the worst time to visit Colorado!

Planning to visit Cancun? Check out the best and worst time to visit Cancun to ensure you have a better travel!

Wondering what is the worst time to visit the Galapagos? This guide has got you covered if you're wondering to take a trip to Galapagos!

Dreams are not what you see in your sleep, Dreams are things which do not let you sleep. – Dr. APJ Abdul Kalam I don’t know the timing of this quote from Dr. Kalam, but I have had a dream

GAINESVILLE, Fla., and CAMBRIDGE, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a clinical...

New longer-term efficacy and safety data from pivotal Phase III ASCEMBL study for recently US-approved Scemblix (asciminib) in patients with PH+ CML-CPEarly findings from YTB323 and PHE885 CAR-T cell therapies

Investegate announcements from NOVARTIS AG CHF0.50(REGD), New data at ASH spotlight Novartis recently approved Scemblix®, next-generation CAR-T platform and expanding hematology portfolio